1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid spread of coronavirus resulting in large number of deaths
5.1.1.2. Increasing R&D initiatives for effective therapeutics
5.1.1.3. Government support and grants for COVID-19 clinical trials
5.1.2. Restraints
5.1.2.1. Complexities in trial management during COVID-19
5.1.2.2. Risk of causing serious side effects or being uncomfortable.
5.1.3. Opportunities
5.1.3.1. Collaborative efforts of pharma and technology firms
5.1.3.2. Rising investment from importing countries
5.1.4. Challenges
5.1.4.1. Limited supportive infrastructure, skills, and technology in developing areas around the world
5.2. Cumulative Impact of COVID-19

6. COVID-19 Clinical Trials Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV

7. COVID-19 Clinical Trials Market, by Product
7.1. Introduction
7.2. Therapeutics
7.3. Vaccines

8. Americas COVID-19 Clinical Trials Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific COVID-19 Clinical Trials Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa COVID-19 Clinical Trials Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbvie
12.2. Bioclinica
12.3. BioNTech SE
12.4. Covance
12.5. Gilead Sciences Inc.
12.6. GlaxoSmithKline
12.7. ICON Plc
12.8. Inovio Pharmaceuticals
12.9. IQVIA
12.10. Johnson & Johnson
12.11. Medidata Solutions
12.12. Moderna
12.13. Novartis
12.14. Novavax
12.15. NOVOTECH
12.16. Parexel
12.17. Pfizer
12.18. PPD, Inc.
12.19. PRA Health Sciences
12.20. Quanticate
12.21. Takeda

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL COVID-19 CLINICAL TRIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL COVID-19 CLINICAL TRIALS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE, 2027
FIGURE 6. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 15. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PRODUCT, 2027
FIGURE 17. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY THERAPEUTICS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY VACCINES, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY VACCINES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. AMERICAS COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 22. ARGENTINA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 23. BRAZIL COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 24. CANADA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 25. MEXICO COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. ASIA-PACIFIC COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. AUSTRALIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. CHINA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. INDIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. INDONESIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. JAPAN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. MALAYSIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. PHILIPPINES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. SINGAPORE COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. SOUTH KOREA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. TAIWAN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. THAILAND COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. FRANCE COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. GERMANY COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. ITALY COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. NETHERLANDS COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. QATAR COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. RUSSIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. SAUDI ARABIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. SOUTH AFRICA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. SPAIN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED KINGDOM COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. GLOBAL COVID-19 CLINICAL TRIALS MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL COVID-19 CLINICAL TRIALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COVID-19 CLINICAL TRIALS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL COVID-19 CLINICAL TRIALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL COVID-19 CLINICAL TRIALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. AMERICAS COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 12. ARGENTINA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 13. BRAZIL COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 14. CANADA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. MEXICO COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. AUSTRALIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. CHINA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. INDIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. INDONESIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. JAPAN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. MALAYSIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. PHILIPPINES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. SINGAPORE COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. SOUTH KOREA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. TAIWAN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. THAILAND COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. FRANCE COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. GERMANY COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. ITALY COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. NETHERLANDS COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. QATAR COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. RUSSIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. SAUDI ARABIA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SOUTH AFRICA COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SPAIN COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. UNITED KINGDOM COVID-19 CLINICAL TRIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL COVID-19 CLINICAL TRIALS MARKET: SCORES
TABLE 42. GLOBAL COVID-19 CLINICAL TRIALS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL COVID-19 CLINICAL TRIALS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL COVID-19 CLINICAL TRIALS MARKET: RANKING
TABLE 45. GLOBAL COVID-19 CLINICAL TRIALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL COVID-19 CLINICAL TRIALS MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL COVID-19 CLINICAL TRIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL COVID-19 CLINICAL TRIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL COVID-19 CLINICAL TRIALS MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL COVID-19 CLINICAL TRIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL COVID-19 CLINICAL TRIALS MARKET: LICENSE & PRICING

Companies Mentioned

Abbvie
Bioclinica
BioNTech SE
Covance
Gilead Sciences Inc.
GlaxoSmithKline
ICON Plc
Inovio Pharmaceuticals
IQVIA
Johnson & Johnson
Medidata Solutions
Moderna
Novartis
Novavax
NOVOTECH
Parexel
Pfizer
PPD, Inc.
PRA Health Sciences
Quanticate
Takeda